The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 499.50
Bid: 498.00
Ask: 499.50
Change: 4.50 (0.91%)
Spread: 1.50 (0.301%)
Open: 492.00
High: 499.50
Low: 492.00
Prev. Close: 495.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

22 Apr 2013 07:00

RNS Number : 8378C
Creston PLC
22 April 2013
 



 

 

22 April 2013

Creston plc

 

Trading Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, provides an update on trading for the year ended 31 March 2013 ahead of its full year results for the period.

 

The Group expects to report full year revenue of £75 million (2012: £74.9 million) and to be in line with consensus Group Headline PBT. Following a strong cash conversion, and with operating cash flow ahead of Board expectations, the Group expects to be in a net cash position of over £10 million at the year end. This includes £6.5 million of the previously announced £7.2 million (including VAT) received as a reverse premium and contribution to the agreed dilapidations obligation for the Group's new London office.

 

Following a working partnership of over 20 years with Sanofi Pasteur, Cooney/Waters' contract with the client came to an end during the fourth quarter of the financial year just ended. Appropriate cost reductions were made in the fourth quarter to mitigate this revenue reduction, and it is expected that both the estimated future deferred consideration and the carrying value of goodwill for the Cooney/Waters Group will be reduced at the year end. On the back of the agency's excellent reputation for providing communications support, it has already begun to replace part of the Sanofi Pasteur revenue through developing a new client relationship.

 

The Group's most recent acquisition, DJM Digital Solutions Limited, is performing well and has been involved in several new business wins with other companies within the Health division.

 

There have been a number of other recent new business successes across the Group's divisions, most notably within Communications. All of the Group's agencies in its Communications division, as well as Red Door Communications from its Health division, have been appointed on a three year term to the UK Government Procurement Service's roster for marketing services (which includes digital marketing). The exact process to determine how work will be allocated to the agencies on the roster is still to be finalised. However, given the size of the budget and the fact that Creston is the most represented marketing communications group on this roster, it is expected to become a top five client for the Group during the three year appointment. In a second major win for the Communications division, it was announced on 19 April 2013 that Reckitt Benckiser UK is consolidating all of its digital activity across its portfolio of 19 brands into TMW.

 

The recovery within the Group's Insight division continued during the second half, and the Board expects it to report a stronger second half compared with the first half of the financial year.

 

Creston will announce its full year results for the year ended 31 March 2013 on Wednesday 12 June 2013.

 

-ends-

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson/Matthew Neal

 

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to truly understand, influence and inspire consumers and it's that insight-led intelligence that drives our creativity. www.creston.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUWWCUPWGQB
Date   Source Headline
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.